ahlam1399
02-18-2016, 01:10 PM
UPDATE 1-UK cost agency queries value of $700,000-a-year Alexion drug
LONDON, Feb 18 (Reuters) - An enzyme treatment from Alexion Pharmaceuticals costing 491,992 pounds ($704,630) a year may be worth using in babies with a rare disorder but does **t represent good value for all patients, Britain's healthcare cost watchdog said.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4dac7f94/sc/13/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=HZZPClIrYMw:_ZJ3YHXojf8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=HZZPClIrYMw:_ZJ3YHXojf8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=HZZPClIrYMw:_ZJ3YHXojf8:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=HZZPClIrYMw:_ZJ3YHXojf8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=HZZPClIrYMw:_ZJ3YHXojf8:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/HZZPClIrYMw
LONDON, Feb 18 (Reuters) - An enzyme treatment from Alexion Pharmaceuticals costing 491,992 pounds ($704,630) a year may be worth using in babies with a rare disorder but does **t represent good value for all patients, Britain's healthcare cost watchdog said.
http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4dac7f94/sc/13/mf.gif?resize=1%2C1 http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=HZZPClIrYMw:_ZJ3YHXojf8:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=HZZPClIrYMw:_ZJ3YHXojf8:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=HZZPClIrYMw:_ZJ3YHXojf8:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=HZZPClIrYMw:_ZJ3YHXojf8:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=HZZPClIrYMw:_ZJ3YHXojf8:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/HZZPClIrYMw